These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7995636

  • 1. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.
    Uehara Y, Hirawa N, Kawabata Y, Suzuki T, Ohshima N, Oka K, Ikeda T, Goto A, Toyo-oka T, Kizuki K.
    Hypertension; 1994 Dec; 24(6):770-8. PubMed ID: 7995636
    [Abstract] [Full Text] [Related]

  • 2. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.
    Uehara Y, Hirawa N, Numabe A, Kawabata Y, Ikeda T, Gomi T, Gotoh A, Omata M.
    Am J Hypertens; 1997 May; 10(5 Pt 2):83S-88S. PubMed ID: 9160787
    [Abstract] [Full Text] [Related]

  • 3. Regression of glomerular injury by kallikrein infusion in Dahl salt-sensitive rats is a bradykinin B2-receptor-mediated event.
    Hirawa N, Uehara Y, Suzuki T, Kawabata Y, Numabe A, Gomi T, lkeda T, Kizuki K, Omata M.
    Nephron; 1999 Feb; 81(2):183-93. PubMed ID: 9933754
    [Abstract] [Full Text] [Related]

  • 4. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
    Hirawa N, Uehara Y, Kawabata Y, Ohshima N, Ono H, Nagata T, Gomi T, Ikeda T, Goto A, Yagi S.
    J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
    [Abstract] [Full Text] [Related]

  • 5. Subpressor dose of angiotensin II increases susceptibility to the haemodynamic injury of blood pressure in Dahl salt-sensitive rats.
    Hirawa N, Uehara Y, Kawabata Y, Numabe A, Ohshima N, Ono H, Gomi T, Ikeda T, Yagi S, Toyo-oka T.
    J Hypertens; 1995 Jan; 13(1):81-90. PubMed ID: 7759856
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats.
    Chao J, Zhang JJ, Lin KF, Chao L.
    Kidney Int; 1998 Oct; 54(4):1250-60. PubMed ID: 9767541
    [Abstract] [Full Text] [Related]

  • 7. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
    Chao J, Zhang JJ, Lin KF, Chao L.
    Hum Gene Ther; 1998 Jan 01; 9(1):21-31. PubMed ID: 9458239
    [Abstract] [Full Text] [Related]

  • 8. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats.
    Wang C, Chao C, Chen LM, Chao L, Chao J.
    Am J Physiol; 1996 Oct 01; 271(4 Pt 2):F824-30. PubMed ID: 8898012
    [Abstract] [Full Text] [Related]

  • 9. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
    Ideishi M, Miura S, Sakai T, Sasaguri M, Misumi Y, Arakawa K.
    J Hypertens; 1994 Jun 01; 12(6):653-61. PubMed ID: 7963490
    [Abstract] [Full Text] [Related]

  • 10. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
    Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J.
    Kidney Int; 2004 Aug 01; 66(2):722-32. PubMed ID: 15253727
    [Abstract] [Full Text] [Related]

  • 11. Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats.
    Nishikimi T, Mori Y, Kobayashi N, Tadokoro K, Wang X, Akimoto K, Yoshihara F, Kangawa K, Matsuoka H.
    Hypertension; 2002 Jun 01; 39(6):1077-82. PubMed ID: 12052845
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats.
    Zhang JJ, Chao L, Chao J.
    Stroke; 1999 Sep 01; 30(9):1925-31; discussion 1931-2. PubMed ID: 10471446
    [Abstract] [Full Text] [Related]

  • 13. Kallikrein excretion in Dahl salt-sensitive and salt-resistant rats with native and transplanted kidneys.
    Churchill PC, Churchill MC, Bidani AK, Rabito SF.
    Am J Physiol; 1995 Nov 01; 269(5 Pt 2):F710-7. PubMed ID: 7503238
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats.
    Uehara Y, Numabe A, Hirawa N, Kawabata Y, Iwai J, Ono H, Matsuoka H, Takabatake Y, Yagi S, Sugimoto T.
    J Hypertens; 1991 Aug 01; 9(8):719-28. PubMed ID: 1655882
    [Abstract] [Full Text] [Related]

  • 15. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K, Takeyama K, Minato H, Fukuya F, Kawahara S, Kadokawa T.
    Arzneimittelforschung; 1986 Aug 01; 36(1):77-83. PubMed ID: 3006712
    [Abstract] [Full Text] [Related]

  • 16. Hypertension in Dahl salt-sensitive rats: biochemical and immunohistochemical studies.
    Bouhnik J, Richoux JP, Huang H, Savoie F, Baussant T, Alhenc-Gelas F, Corvol P.
    Clin Sci (Lond); 1992 Jul 01; 83(1):13-22. PubMed ID: 1325316
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats.
    Dobrzynski E, Yoshida H, Chao J, Chao L.
    Immunopharmacology; 1999 Oct 15; 44(1-2):57-65. PubMed ID: 10604525
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K, Zhang X, Dunham EW, Zimmerman BG.
    Hypertension; 1996 Jan 15; 27(1):85-9. PubMed ID: 8591894
    [Abstract] [Full Text] [Related]

  • 20. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O, Shimamoto K.
    Adv Exp Med Biol; 1989 Jan 15; 247A():39-48. PubMed ID: 2532450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.